High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

(2022) Zhen-duo Shi et al.   Molecular Cancer

Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma

(2021) Jiawei Zhou et al.   Aging-US

HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription

(2021) Yi Liang et al.   EXPERIMENTAL CELL RESEARCH

HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression

(2020) Huajie Song et al.   Journal of Hematology & Oncology

Novel prognostic molecular markers in lung cancer (Review)

(2020) Michał Puderecki et al.   Oncology Letters

LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U

(2020) Jianyuan Pan et al.   Cancer Medicine

hnRNPU Functions as a Novel Therapeutic Target of c‐Myc in the Progression of Hepatocellular Carcinoma

(2020) Biao Zhang et al.   FEBS LETTERS

RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers

(2020) Derrick Lin et al.   ORAL ONCOLOGY

Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator

(2019) Magdalena Ogłuszka et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

(2019) Narjust Duma et al.   MAYO CLINIC PROCEEDINGS

RUVBL1, a novel C-RAF-binding protein, activates the RAF/MEK/ERK pathway to promote lung cancer tumorigenesis

(2018) Hui Guo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma

(2018) Qi Sun et al.   Biomed Research International

Long noncoding RNA SFTA1P promoted apoptosis and increased cisplatin chemosensitivity via regulating the hnRNP-U-GADD45A axis in lung squamous cell carcinoma

(2017) Ling Li et al.   Oncotarget

Progress and prospects of early detection in lung cancer

(2017) Sean Blandin Knight et al.   Open Biology

Heterogeneous nuclear ribonucleoprotein U-like 1 and Poly (ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with the prognosis

(2017) Ting Xu et al.   Cancer Biomarkers

Downregulation of RUVBL1 inhibits proliferation of lung adenocarcinoma cells by G1/S phase cell cycle arrest via multiple mechanisms

(2016) Xiao-Shuai Yuan et al.   TUMOR BIOLOGY

Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients’ Survival

(2015) Xiang Zhang et al.   PLoS One

Nuclear Matrix Factor hnRNP U/SAF-A Exerts a Global Control of Alternative Splicing by Regulating U2 snRNP Maturation

(2012) Rui Xiao et al.   MOLECULAR CELL

The Role of Nuclear Matrix Proteins Binding to Matrix Attachment Regions (MARs) in Prostate Cancer Cell Differentiation

(2012) Paola Barboro et al.   PLoS One

Integrated regulation of PIKK-mediated stress responses by AAA+ proteins RUVBL1 and RUVBL2

(2012) Natsuko Izumi et al.   Nucleus

hnRNP-U is a specific DNA-dependent protein kinase substrate phosphorylated in response to DNA double-strand breaks

(2009) Fredrik M. Berglund et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism

(2009) Valérie Haurie et al.   HEPATOLOGY